Urosurge Inc.
This article was originally published in Start Up
Executive Summary
Implantable Devices; UroSurge is building a portfolio of products targeted to urologists and Ob/Gyn's with new technologies for the management of incontinence, BPH and kidney or bladder stones. For ISD incontinence, the UroSurge's {Self-Detachable Balloon System} provides supports around the sphincter muscle via catheters which deliver a microballoon filled with hydrogel.
You may also be interested in...
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.
Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing
Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.